Plasma alpha-synuclein levels in Gr. 1 (control) and Gr.2 (treatment—Nichi Glucan) at baseline and postintervention
| Patient | Baseline (ng/dL) | Postintervention (ng/dL) | Fold increase |
| Gr.1 Control | |||
| I | 1.06 | 1.75 | 1.66 |
| II | 0.12 | 1.8 | 15 |
| III | 15.99 | 20.1 | 1.25 |
| IV | 20.41 | 18.6 | 0.91 |
| Gr.2 Treatment | |||
| I | 41.12 | 56.1 | 1.36 |
| II | 0.9 | 26.74 | 29.72 |
| III | 3.67 | 24.1 | 6.57 |
| IV | 0.44 | 11.12 | 25.27 |
| V | 11.38 | 9.6 | 0.84 |
| VI | 24.99 | 28.5 | 1.14 |
| VII | 0.45 | 70 | 155.5 |
| VIII | 2.46 | 11.98 | 4.87 |
| IX | 2.18 | 2.4 | 1.1 |